Silengo–Lerone–Pelizzo syndrome

From WikiMD's WELLNESSPEDIA

Silengo–Lerone–Pelizzo Syndrome

Silengo–Lerone–Pelizzo syndrome is a rare genetic disorder characterized by a combination of congenital anomalies. It was first described by Silengo, Lerone, and Pelizzo in the late 20th century. This syndrome is part of a group of disorders that affect multiple systems in the body, leading to a variety of clinical manifestations.

Clinical Features[edit]

Patients with Silengo–Lerone–Pelizzo syndrome typically present with a range of symptoms that may include:

Genetics[edit]

The genetic basis of Silengo–Lerone–Pelizzo syndrome is not fully understood, but it is believed to follow an autosomal recessive inheritance pattern. This means that both parents must carry one copy of the mutated gene, and the child must inherit both copies to be affected.

Diagnosis[edit]

Diagnosis of Silengo–Lerone–Pelizzo syndrome is primarily clinical, based on the presence of characteristic features. Genetic testing may be used to confirm the diagnosis and to differentiate it from other syndromes with overlapping symptoms.

Management[edit]

Management of Silengo–Lerone–Pelizzo syndrome is symptomatic and supportive. It often involves a multidisciplinary approach, including:

Prognosis[edit]

The prognosis for individuals with Silengo–Lerone–Pelizzo syndrome varies depending on the severity of the symptoms and the presence of life-threatening complications. Early intervention and comprehensive care can improve quality of life and outcomes.

Also see[edit]

References[edit]

  • Silengo, M., Lerone, M., & Pelizzo, G. (Year). Title of the original paper. Journal Name, Volume(Issue), Page numbers.


NIH genetic and rare disease info[edit]

Silengo–Lerone–Pelizzo syndrome is a rare disease.





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.